Merck’s Stock Fluctuates Based on Molnupiravir’s Efficacy Concerns

Merck’s Stock Fluctuates Based on Molnupiravir’s Efficacy Concerns

By Christy Gren - Feb 17, 2022

On November 26, the company admitted that its pill was less effective in reducing hospitalizations and deaths than was previously estimated.

Read More